Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-ARRX for Lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where RITUXIMAB-ARRX was used for Lymphoma.

Most Reported Side Effects for RITUXIMAB-ARRX

Side Effect Reports % Deaths Hosp.
Product storage error 165 47.6% 0 0
Circumstance or information capable of leading to medication error 116 33.4% 0 0
Off label use 56 16.1% 9 14
Intercepted product administration error 51 14.7% 0 0
Accidental exposure to product 17 4.9% 0 0
Intercepted product preparation error 16 4.6% 0 0
Fatigue 14 4.0% 6 8
Infusion related reaction 14 4.0% 6 7
Drug ineffective 12 3.5% 6 8
Dyspnoea 12 3.5% 4 6
Malaise 12 3.5% 4 5
Pruritus 12 3.5% 4 5
Drug intolerance 10 2.9% 6 8
Rash 10 2.9% 5 6
Rheumatoid arthritis 9 2.6% 6 8

Other Indications for RITUXIMAB-ARRX

Product used for unknown indication (247) Rheumatoid arthritis (15) Off label use (9) Non-hodgkin's lymphoma (8) Immune thrombocytopenia (7) Multiple sclerosis (6) Diffuse large b-cell lymphoma (5)

Other Drugs Used for Lymphoma

RITUXIMAB (3,142) CYCLOPHOSPHAMIDE (1,729) VINCRISTINE (1,452) LENALIDOMIDE (1,427) DOXORUBICIN (1,420) ETOPOSIDE (915) IBRUTINIB (896) PREDNISONE (672) METHOTREXATE (647) CYTARABINE (645)

Related Pages

RITUXIMAB-ARRX Full Profile All Lymphoma Drugs RITUXIMAB-ARRX Demographics RITUXIMAB-ARRX Timeline